{"id":949843,"date":"2026-04-08T08:39:02","date_gmt":"2026-04-08T12:39:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/"},"modified":"2026-04-08T08:39:02","modified_gmt":"2026-04-08T12:39:02","slug":"equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/","title":{"rendered":"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists"},"content":{"rendered":"
\n

LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for poster presentations at\u00a0IMMUNOLOGY2026\u2122<\/a>, the annual meeting of the American Association of Immunologists taking place in Boston, Massachusetts, April 15-19, 2026.<\/p>\n

\u201cWe are excited to share these preclinical findings that support the differentiated profile of EQ504 as a potent AhR modulator, with the potential to influence both immune cell responses and barrier restoration,\u201d said Dr. Stephen Connelly, Chief Scientific Officer of Equillium. \u201cTogether, these attributes are particularly important in diseases such as ulcerative colitis, where both reducing inflammation and improving mucosal healing are critical to achieving meaningful outcomes for patients.\u201d<\/p>\n

\n Details of the presentations: <\/strong><\/p>\n

Abstract title:<\/strong>
\n EQ504: A Novel AhR Modulator That Promotes Immune Tolerance Through Il-10 and Il-22 Cytokine Release<\/em>
\n
\n Session:<\/strong> Immune Response Regulation: Cellular Mechanisms I
Presentation Type:<\/strong> Poster Abstract Presentation
Presentation Location & Time:<\/strong> Exhibit Hall, Thursday April 16, 2026
Session Time:<\/strong> 9:00 AM – 4:30 PM EDT
Poster Board Number:<\/strong> 242
Speaker at Poster:<\/strong> 2:30 PM –\u00a03:30 PM EDT<\/p>\n

Abstract title:<\/strong>EQ504, a Potent AhR Modulator, Promotes Epithelial Repair and Barrier Restoration Compared to Clinically Validated AhR Agonists<\/em>
Session:<\/strong> Immunology of Barrier Surfaces
Presentation Type:<\/strong> Poster Abstract Presentation
Presentation Location & Time:<\/strong> Exhibit Hall, Saturday April 18, 2026
Session Time:<\/strong> 9:00 AM – 4:30 PM EDT
Poster Board Number:<\/strong> 517
Speaker at Poster: <\/strong>11:30 AM –\u00a012:30 PM EDT<\/p>\n

Following each presentation, the posters will be available on the Presentations<\/a> page, located under the Technology section on equilliumbio.com<\/a>.<\/p>\n

\n About EQ504<\/strong>
\n
EQ504 is an investigational potent and selective aryl hydrocarbon receptor (AhR) modulator with a multi-modal, non-immunosuppressive mechanism of action designed to be complementary to other inflammation and immunology agents. AhR is critical to barrier organ tissue physiology and immunology, maintaining barrier function and promoting tissue repair and regeneration, while regulating resident immune cells with anti-inflammatory responses. EQ504\u2019s preclinical properties provide the potential for targeted, local delivery via enteric coating for the treatment of ulcerative colitis and other gastrointestinal diseases or inhaled formulations for the treatment of inflammatory lung diseases.<\/p>\n

\n About Equillium<\/strong>
\n
Equillium is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders. The company\u2019s lead therapeutic candidate is EQ504, a potent and selective aryl hydrocarbon receptor (AhR) modulator designed with a multi-modal, non-immunosuppressive mechanism of action to be complementary to other inflammation and immunology agents. EQ504 is an investigational therapeutic program with potential for targeted, local delivery via enteric coating for the treatment of ulcerative colitis and other gastrointestinal diseases or inhaled formulations for the treatment of inflammatory lung diseases.<\/p>\n

For more information, visit\u00a0www.equilliumbio.com<\/a>.<\/p>\n

\n Investor Contact\u00a0<\/strong>
\n
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for poster presentations at\u00a0IMMUNOLOGY2026\u2122, the annual meeting of the American Association of Immunologists taking place in Boston, Massachusetts, April 15-19, 2026. \u201cWe are excited to share these preclinical findings that support the differentiated profile of EQ504 as a potent AhR modulator, with the potential to influence both immune cell responses and barrier restoration,\u201d said Dr. Stephen Connelly, Chief Scientific Officer of Equillium. \u201cTogether, these attributes are particularly important in diseases such as ulcerative colitis, where both reducing inflammation and improving mucosal healing are critical … <\/p>\n

Continue reading “Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-949843","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEquillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for poster presentations at\u00a0IMMUNOLOGY2026\u2122, the annual meeting of the American Association of Immunologists taking place in Boston, Massachusetts, April 15-19, 2026. \u201cWe are excited to share these preclinical findings that support the differentiated profile of EQ504 as a potent AhR modulator, with the potential to influence both immune cell responses and barrier restoration,\u201d said Dr. Stephen Connelly, Chief Scientific Officer of Equillium. \u201cTogether, these attributes are particularly important in diseases such as ulcerative colitis, where both reducing inflammation and improving mucosal healing are critical … Continue reading "Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-08T12:39:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists\",\"datePublished\":\"2026-04-08T12:39:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/\"},\"wordCount\":466,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/\",\"name\":\"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==\",\"datePublished\":\"2026-04-08T12:39:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/","og_locale":"en_US","og_type":"article","og_title":"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists - Market Newsdesk","og_description":"LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for poster presentations at\u00a0IMMUNOLOGY2026\u2122, the annual meeting of the American Association of Immunologists taking place in Boston, Massachusetts, April 15-19, 2026. \u201cWe are excited to share these preclinical findings that support the differentiated profile of EQ504 as a potent AhR modulator, with the potential to influence both immune cell responses and barrier restoration,\u201d said Dr. Stephen Connelly, Chief Scientific Officer of Equillium. \u201cTogether, these attributes are particularly important in diseases such as ulcerative colitis, where both reducing inflammation and improving mucosal healing are critical … Continue reading \"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-08T12:39:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists","datePublished":"2026-04-08T12:39:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/"},"wordCount":466,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/","name":"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==","datePublished":"2026-04-08T12:39:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTQ0MCM3NTIzMzY4IzUwMDE1Mjg5Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/equillium-announces-poster-presentations-at-immunology2026-the-annual-meeting-of-the-american-association-of-immunologists\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Equillium Announces Poster Presentations at IMMUNOLOGY2026\u2122, the Annual Meeting of the American Association of Immunologists"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=949843"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949843\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=949843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=949843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=949843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}